Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Jacq

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
ACS Chemical Biology|November 1, 2016
Quantitative Chemical Proteomic Profiling of Ubiquitin Specific Proteases in Intact Cancer CellsJennifer A Ward, Lauren McLellan, Martin Stockley, et al.
ACS Chemical Neuroscience|September 24, 2025
Deubiquitinating Enzyme UCH-L1 Regulates Neuronal Ca<sup>2+</sup> SignalingMarie Perrier, Desirée Loreth, Johannes Brand, et al.
Scientific Reports|December 31, 2024
Inhibition of AKT enhances chemotherapy efficacy and synergistically interacts with targeting of the Inhibitor of apoptosis proteins in oesophageal adenocarcinomaLeanne Stevenson, Lauren Cairns, Xiaodun Li, et al.
Human Molecular Genetics|January 8, 2017
A population-based analysis of germline BAP1 mutations in melanomaSally J O'Shea, Carla Daniela Robles-Espinoza, Lauren McLellan, et al.
Molecular Cancer Therapeutics|August 13, 2009
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cellsFrédéric Colland, Etienne Formstecher, Xavier Jacq, et al.
Journal of Medicinal Chemistry|February 12, 2013
Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activityKevin M Foote, Kevin Blades, Anna Cronin, et al.
Clinical and Translational Medicine|April 11, 2024
USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGFAnamarija Jurisic, Pei-Ju Sung, Mark Wappett, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
ACS Chemical Biology|November 1, 2016
Quantitative Chemical Proteomic Profiling of Ubiquitin Specific Proteases in Intact Cancer CellsJennifer A Ward, Lauren McLellan, Martin Stockley, et al.
ACS Chemical Neuroscience|September 24, 2025
Deubiquitinating Enzyme UCH-L1 Regulates Neuronal Ca<sup>2+</sup> SignalingMarie Perrier, Desirée Loreth, Johannes Brand, et al.
Scientific Reports|December 31, 2024
Inhibition of AKT enhances chemotherapy efficacy and synergistically interacts with targeting of the Inhibitor of apoptosis proteins in oesophageal adenocarcinomaLeanne Stevenson, Lauren Cairns, Xiaodun Li, et al.
Human Molecular Genetics|January 8, 2017
A population-based analysis of germline BAP1 mutations in melanomaSally J O'Shea, Carla Daniela Robles-Espinoza, Lauren McLellan, et al.
Molecular Cancer Therapeutics|August 13, 2009
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cellsFrédéric Colland, Etienne Formstecher, Xavier Jacq, et al.
Journal of Medicinal Chemistry|February 12, 2013
Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activityKevin M Foote, Kevin Blades, Anna Cronin, et al.
Clinical and Translational Medicine|April 11, 2024
USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGFAnamarija Jurisic, Pei-Ju Sung, Mark Wappett, et al.
Pageof 2